Home / Resources / News / Suzanne Kincaid Named to Distinguished 2020 PharmaVOICE 100 List of Most Inspiring People

The Aperio Blog

Home / Resources / News / Suzanne Kincaid Named to Distinguished 2020 PharmaVOICE 100 List of Most Inspiring People

Suzanne Kincaid Named to Distinguished 2020 PharmaVOICE 100 List of Most Inspiring People

August 3, 2020

Aperio Clinical Outcomes is thrilled to announce that Suzanne Kincaid, Chief Operating Officer for Aperio, has been named to the PharmaVOICE 100 list of Most Inspiring People in the life-sciences industry.

PharmaVOICE 100 is the only awards program to recognize individuals spanning all sectors of the life-sciences industry — from academia to nonprofit organizations to big pharma to emerging biotech companies to all types of innovative companies that provide molecule-to-market services in support of moving the needle to benefit patients around the world. The result is a dynamic mix of people across a range of disciplines who are making meaningful contributions in their fields of influence. This diverse group of individuals is also unique in that they represent a wide variety of functional areas — ranging from the clinic to the C-suite. The PharmaVOICE 100 issue recognizes its distinguished honorees across multiple categories each year. Suzanne was named to the Commanders & Chiefs category. According to PharmaVOICE, the forward-thinking leaders that are named to this category are strategically positioning their companies for success and inspiring their teams to achieve far-reaching goals as they navigate complex industry challenges.

According to Taren Grom, editor and co-founder of PharmaVOICE magazine, “When we introduced the PharmaVOICE 100 most inspiring people in the life-sciences industry more than 15 years ago it began a movement. Our goal is to capture that intangible measure of a person’s influence: inspiration. Each year, our community puts thoughtful consideration into distinguishing the individuals who are leading the charge in terms of inspired leadership, creativity, breakthrough science, corporate excellence, patient advocacy, mentorship and sponsorship, technology development, and so on — in short the individuals who are driving change and redefining the landscape of the life-sciences ecosystem.”

When speaking of Suzanne’s recognition, CEO Faye Woolf said “I couldn’t be more proud of Suzanne. Her gift of leadership and passion for clinical research and helping raise up the next generation of clinical researchers is inspiring to all of us who work alongside her every day. What makes this recognition so special, is that we now get to share all of the great things that inspire us about Suzanne with the rest of the life-sciences industry!”

About Aperio Clinical Outcomes

Aperio Clinical Outcomes provides full, customizable clinical research services across multiple therapeutic areas. Dedicated to transparent interactions with clients, Aperio also offers consulting services in Quality Assurance, Strategic Resourcing, and practical application of the latest Clinical Trial Technology.

In an industry flooded with data, metrics and technology, Aperio remains steadfastly focused on the most important part of the process: people. From start-up to close out and every point in between, Aperio works with its partners to deliver outcomes that will improve patient care and save lives.

Aperio Clinical Outcomes.
We make it clear.

Share this...

Learn how Aperio Clinical Outcomes can help you.
Contact us today.